Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum 4D Molecular Therapeutics Inc FDMT

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular... see more

Bullboard (NDAQ:FDMT)

View:
Post by whytestockson Sep 23, 2024 6:30pm

4DMT Announces Presentation at the 2024 North American Cysti

JUST IN: $FDMT 4DMT Announces Presentation at the 2024 North American Cystic Fibrosis ConferenceEMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, ...more  
38
Post by MikeTesteron Aug 02, 2024 4:04pm

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT): A Promising B

https://beyondspx.com/2024/07/31/4d-molecular-therapeutics-inc-nasdaqfdmt-a-promising-biotech-poised-for-growth/
26
Post by whytestockson Jul 11, 2024 12:49pm

Learn to Evaluate (FDMT) using the Charts

BREAKING NEWS: $FDMT Learn to Evaluate (FDMT) using the Charts2024-07-11 10:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks ...more  
55
Post by whytestockson Jun 08, 2024 5:00pm

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 P

Just In: $FDMT 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at ...more  
105
Post by whytestockson Jun 06, 2024 7:00pm

4DMT Presents Positive Interim Data from Phase 1/2 AEROW Cli

News; $FDMT 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis ...more  
51
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities